American Board of Orthodontics (ABO) Practice Exam 2026 – All-in-One Resource to Master Your Orthodontics Certification!

Bisphosphonates are a class of medications that inhibit bone resorption and are primarily used to treat conditions characterized by excessive bone loss. In young patients, their use is approached with caution due to potential risks such as osteonecrosis and long-term effects on bone growth. However, in specific conditions, the benefits of bisphosphonate therapy can outweigh these risks.

The conditions listed in the correct answer include Osteogenesis Imperfecta, which is a genetic disorder that impacts collagen formation and leads to brittle bones; Juvenile Paget's disease, characterized by abnormal bone remodeling; anorexia-related osteoporosis, which involves bone density loss due to nutritional deficiencies; and certain cases post-renal transplant, where bisphosphonates can help manage bone density loss associated with glucocorticoid use or other medications that affect bone metabolism. In these circumstances, the therapeutic advantages of stabilizing or improving bone density and reducing fracture risk are significant.

The other options, while relevant to various medical issues, do not reflect the specific indications for bisphosphonate use in pediatric populations. For instance, adolescent growth disorders may not justify the potential adverse effects related to bone maturation. Chronic pain syndromes and severe dental infections are also not primary indications for bisphosph